Dr. Alfred A. Van Baak, MD

Dr. Van Baak practices at Presbyterian Medical Group in Albuquerque, New Mexico.

Dr. Van Baak's NPI, 1528355153, was assigned on July 4, 2011. Dr. Van Baak holds New Mexico license MD2016-0051.

Dr. Van Baak's primary practice is Presbyterian Medical Group, at 6100 Pan American NE Fwy, Albuquerque, NM 87109 in Bernalillo County. The practice phone is (505) 823-8556.

Dr. Van Baak's primary practice is Presbyterian Medical Group in Albuquerque, New Mexico. Dr. Van Baak is also affiliated with Presbyterian Hospital. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Van Baak to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Van Baak practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Van Baak's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Van Baak is licensed in New Mexico.

CMS data shows 589 Medicare services from Dr. Van Baak across 12 procedure codes in 2024, for 355 Medicare patients. Medicare paid $36,998 for them.

CMS counts 355 Medicare patients who saw Dr. Van Baak in 2024. The largest group is 65 to 74, with 148 patients. 71% of them have high blood pressure, and 69% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Van Baak's median patient age at 57, with 67% women.

In 2024, Dr. Van Baak wrote 2,354 Medicare Part D claims for 412 patients. 88% of them were for generic drugs. CMS names the drug for 2,168 of them, across 50 drugs with 11 or more claims each, at $388,622 in total drug cost. In 2023, CMS named 1,991 claims across 44 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Van Baak for performance year 2024, reported as part of a group. Dr. Van Baak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Van Baak as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 272 general payments to Dr. Van Baak from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 83% of the total. LivaNova USA, Inc. paid the most, $2,695.